. The expression of CK7, additional expression of vimentin, and clinical and histopathological findings enabled us to confirm that six cell lines had been established from primary ovarian cancers. Two of the six cell lines were positive for CK20, although CK20 was not expressed in the original tumours. The heterotransplanted tumours produced by CK20-positive cells also expressed CK20. This is the first report of ovarian carcinoma cell lines that express CK20 irrespective of their histological type. CK20 has been found in all colon carcinoma cell lines, but only in the mucinous type of ovarian tumours. These new ovarian carcinoma cell lines will therefore provide a relevant experimental system for elucidating the regulatory control mechanisms of intermediate filament expression.
The characteristics of ovarian cancer have been studied in primary tumours and in established cell lines that provide a reproducible source of tumour material (Buick et al, 1985; Horowitz et al, 1985; Hill et al, 1987; Wolf et al, 1987; Langdon et al, 1988 ; Niekerk et al, 1988; Crickard et al, 1989; Hills et al, 1989; Wong et al, 1990; Mobus et al, 1992; Fuchtner et al, 1993; Morimitsu et al, 1993; Van Den Berg-Bakker et al, 1993) . The characterization of relevant ovarian carcinoma cell lines is considered to be worthwhile for the investigation of their epithelial nature and derivation, and to demonstrate no contamination with fibroblasts. There have been only a few studies on the expression of intermediate filament (IF) in ovarian cancer cell lines. The cytokeratins (CKs) are known to be composed of a family of at least 20 different polypeptides and to be distributed in both normal and neoplastic tissues in a tissue-specific manner . Epithelial ovarian tumours are thought to arise from the ovarian surface epithelium or mesothelium (Scully, 1979 ; Van Niekerk et al, 1993) . This hypothesis was supported by the presence of the so-called simple CKs 8 and 18 and, in greater amounts, CKs 7 and 19 (Moll et al, 1991) . As most ovarian and colon carcinoma cell lines are derived from adenocarcinomas, differential diagnosis may sometimes be difficult on the basis of the intraoperative situation and the histopathological examination. The difference in the relative expression of CKs 7 and 20 was shown to be helpful in the distinction between primary ovarian carcinomas and metastatic adenocarcinomas of the gastrointestinal tract to the ovary (Wauters et al, 1995; Berezowski et al, 1996) . CK20 has been found throughout all colon carcinoma cell lines and has been described as being the best marker for discriminating between adenocarcinoma cell lines derived from ovarian carcinomas and those derived from colon tumours (M6bus et al, 1994) . The present study was aimed at immunohistochemically analysing IF expression, including that of CKs 7 and 20, in six newly established ovarian carcinoma cell lines that were derived from solid tumours. This study provides preliminary evidence for the expression of CK20 in these ovarian carcinoma cell lines, irrespective of their histological type.
MATERIALS AND METHODS Cell lines
All the cell lines used were established from primary or metastatic solid tumours of human ovarian cancer. Four cell lines, OVISE, OVTOKO, OVMANA and OVSAYO, were derived from clear-cell adenocarcinoma and the other two, OVSAHO and OVKATE, were from serous papillary adenocarcinomas. The growth characteristics of the six cell lines are summarized in Table 1 . Each metastatic tumour, from which OVISE, OVTOKO, OVSAHO or OVKATE were derived, was histologically identical to the original tumour.
Morphological findings
The original tumour tissues, cultured on Lab Tek tissue chamber slides (Nunc, Naperville, IL, USA) at different passages, and xenografted tissues were fixed with 10% formaldehyde solution 829 Antisera (1)-{17) were purchased from Dakopatts (Dako Japan, Kyoto, Japan); (18)- (20) were purchased from Sigma (SigmaAldrich Co., Tokyo, Japan); (21) was purchased from Chemical International (Funakoshi Co., Tokyo, Japan); (22) was purchased from Oncogene Science (Cosmo Bio Co., Tokyo, Japan); (23)- (26) were purchased from Progen Biotechnik (Heidelberg, Germany); and (27) and (28) were purchased from Biomeda (Foster City, CA, USA). Antiserum (29) was kindly provided by Boehringer Mannheim (Tutzing, Germany).
Immunohistochemical procedure Single labelling procedure
The avidin-biotin peroxidase complex method described by Gorai et al (1993) was used for single antigen localization. The single labelling technique was performed at four different passages. Cells cultured on coverslips (18 x 24 mm) were rinsed with phosphatebuffered saline (PBS) and then fixed by immersion first in 70% and then in 100% ethanol for 15 min each at -20°C, and then dried. The coverslips were incubated for 30 min at room temperature with non-immune mouse or rabbit serum before staining with one of the 10-to 1000-fold diluted primary antibodies for 30 min. The coverslips were washed with PBS and then incubated for 30 min with secondary antibody. After additional washing with PBS, the samples were incubated with avidin-conjugated horseradish peroxidase for 30 min. The coverslips were then washed with PBS and reacted with a substrate containing 3,3-diaminobenzidine for 5 min. After they were washed in PBS, the sections were dipped ten times into distilled water and then reacted with 0.5% copper sulphate in normal saline for 5 min. After being dipped several times in distilled water, counterstaining was performed with haematoxylin. The slides were dehydrated in xylene and embedded in synthetic resin.
British Journal of Cancer (1997) 76 (7), [829] [830] [831] [832] [833] [834] [835] An immunohistochemical study of the original ovarian tumours and heterotransplanted tumours was performed on formalin-fixed, paraffin-embedded sections using the avidin-biotin-peroxidase method, as described above. One representative block of each case was deparaffinized and rehydrated in graded alcohols. These sections were incubated in 0.01 M citrate buffer at 95°C for 60 min. The endogenous peroxidase activity was blocked with 0.3% hydrogen peroxide in methanol. The primary antibody was applied for 60 min and was followed by incubation with secondary antibodies for 10 min, and then with an avidin-biotin-peroxidase complex reagent for 10 min at room temperature. Sections were thoroughly washed with PBS between steps. Sections were reacted by immersion in Tris buffer containing 3,3-diaminobenzidine for 5 min.
The staining of the positive control slides (ovarian carcinomas for CK7 and colon carcinomas for CK20) was always positive and that of the negative control slides was negative at each staining. The expression of the antigens is defined as: -, negative; +, < 10% of cells positive; ++, 10-50% of cells positive; +++, > 50% of cells positive.
Double labelling procedure
For double labelling studies of CKs 7 and 20, streptavidin-biotin labelling (Giorno, 1984) and alkaline phosphatase monoclonal anti-alkaline phosphatase procedures (Malik and Daymon, 1982; Cordell et al, 1984) were performed sequentially. The double labelling technique was performed at three different passages. After fixing and drying, the samples were first treated with normal goat serum for 5 min at room temperature. The coverslips were then incubated with one of the primary antisera, diluted 50-to 500-fold with PBS, for 20 min and then washed with PBS. The samples were reacted with a biotinylated secondary goat anti-mouse antibody for 10 min and then washed with Tris buffer. The coverslips were incubated with horseradish peroxidase-labelled streptavidin for 10 min, washed with Tris buffer and then reacted with 4-chloronaphthol for 20 min, giving a blue end product. After they were washed with PBS, the samples were incubated with 0.1 M glycine chloride, pH 2.2, for 2 h and then washed again with PBS. In the second alkaline phosphatase-anti-alkaline phosphatase procedure, the samples were first incubated with a second primary antiserum overnight at 4°C and washed with Tris buffer. The coverslips were reacted with secondary rabbit anti-mouse antibody for 30 min and then washed with Tris buffer. The samples were reacted with mouse alkaline phosphatase-anti-alkaline phosphatase immune complex for 30 min and then washed with Tris buffer. The coverslips were then reacted with substrates of naphthol AS-MX phosphate and Fast Red TR for 20 min, giving a red end product. After counterstaining, the samples were embedded in glycerin. For staining of the original tumours and heterotransplanted tumours, sections were prepared and reacted in the same way as described for the single labelling procedure.
RESULTS Heterotransplantation
The OVISE, OVTOKO, OVSAHO, OVMANA and OVKATE cells produced 1.0-cm-to 1.5-cm-diameter tumours in the subcutis of male Balb/c nude mice from 2-3 months after s.c. transplantation. Histological examination of the tumours showed a structure of sheets passages.
Original tumours
The original tumours yielded various patterns of CK expression. All the tumours were positive for CK7 and negative for CK20. The tumours of colon carcinoma expressed CK20. The tumours from which OVISE, OVSAHO and OVKATE were established expressed CKs 8, 18 and 19, whereas the tumour from which OVTOKO was established was negative for these particular CKs (Table 3) .
Heterotransplanted tumour
The CK expression of the heterotransplanted tumours was similar to that of the original tumours except for that of CK20. All the tumours were positive for CK7, whereas the tumours consisting of CK20-positive OVMANA and OVKATE cells were also positive for CK20 (Figure 2 and Table 4 ).
Double labelling
The double labelling technique showed that OVMANA and OVKATE cell lines were composed of four types of cells: CK7-positive, CK20-positive; CK7-positive, CK20-negative; CK7-negative, CK20-positive; and CK7-negative, CK20-negative cells (Figure 3) . Furthermore, these four types of cells were observed in the heterotransplanted tumours produced by OVMANA and OVKATE cells. In contrast, two types of cell, CK7-positive, CK20-negative, and CK7-negative, CK20-negative, were also observed in the original ovarian tumours from which OVMANA and OVKATE cells were derived.
DISCUSSION
Different human epithelium-derived cell lines have been shown to produce tonofilaments containing different sets of CK polypeptides . Most cell lines express three or four CK polypeptides, including components 8 and 18. Some cell lines (for example produce the small and acidic CK19, which has been identified in some cell cultures (Fuchs and Green, 1981; Wu and Rheinwald, 1981) . The most complex expression of CK polypeptides has been observed in the cell line A-431, which is derived from an epidermoid carcinoma of the vulva. The clonal sublines of A-431 cell line continued to express as many as ten different CK polypeptides . Five of the six cell lines examined in the present study expressed at least six CK polypeptides. OVKATE cells retained the ability to express as many as nine CK proteins. This might reflect the multipotentiality of the differentiation of Mullerian duct-derived epithelia (Moll et al, 1991) . CK20 has only recently been introduced as a new CK polypeptide (Moll et al, 1990 ). CK20 expression is almost entirely confined to the mucosa of the small and large intestine, the gastric foveolar epithelium, the umbrella cells of the urothelium and epidermal Merkel cells . This specificity is maintained in the corresponding tumours. In an immunohistochemical study, 89 out of 92 cases of colorectal adenocarcinomas expressed CK20, whereas 31 out of 34 serous, endometrioid, anaplastic and clear cell ovarian carcinomas were completely negative; the remaining three were essentially negative for CK20 . CK20 has been found in all colon carcinoma cell lines, but not in all ovarian carcinoma cell lines (Mobus et al, 1994) . CK20 was effective in discriminating between metastatic and primary ovarian carcinomas.
The only exception was a group of mucinous ovarian tumours (both adenomas and carcinomas), which consistently expressed CK20, irrespective of their degree of malignancy . This sometimes made it difficult to differentiate between primary and metastatic mucinous adenocarcinomas in the ovary.
In the study reported here (Table 2) , CK20 was expressed in one clear-cell adenocarcinoma cell line and one serous papillary adenocarcinoma cell line. To the best of our knowledge, this is the first report that demonstrates the expression of CK20 in ovarian carcinoma cell lines without regard to their histological type. In addition, CK20-positive cell lines expressed CK7 and vimentin. It has been shown that the expression of simple epithelial CK7 occurs only in ovarian carcinoma cell lines and is completely absent from colon carcinoma cell lines (Ramaekers et al, 1990; Ueda et al, 1993; Mobus et al, 1994) . However, CK7 staining was found in ovarian metastatic tumours from primary gastric and colonic adenocarcinomas (Wauters et al, 1995) . An additional differential marker is vimentin, which has been shown to be strongly expressed in the ovarian carcinoma cell lines, but which is essentially absent from the colon carcinoma cell lines (Viale et al, 1988; Coggi et al, 1989; Mobus et al, 1994; Gorai et al, 1995) . The tumours deriving CK20-positive cell lines have been considered to be primary ovarian carcinoma, thus excluding the possibility of metastasis of colon cancer to the ovary on the basis of clinical and histopathological findings, and a critical review of the original histology by at least two independent pathologists. CK20, however, was not expressed in the original ovarian tumours from which the CK20-positive OVMANA and OVKATE cell lines were derived, although CK20 was positive for colon carcinomas. CK20 was expressed in the heterotransplanted tumours produced by the CK20-expressing cell lines. It has been reported that patterns of CK expression in cultured cells are not decisively correlated with the CK present in the corresponding tissue Green, 1978, 1981; Sun and Green, 1978; Doran et al, 1980; Wu and Rheinwald, 1981) . The fact that CK20 was newly expressed in ovarian carcinoma cells other than mucinous tumours is of clinical importance when we consider the origin of CK20-positive cells. It is possible that the patternof expression is altered during the establishment of cell lines. The regulatory control mechanisms of CK20 expression in ovarian carcinoma cell lines from CK20-negative ovarian tissues remain to be elucidated. First, it may be that the loss of control mechanisms in individual cells occurs, similar to the case for CKs 8 and 18 (Knapp and Franke, 1989) . In SV40-transformed fibroblasts, the CK18 gene was constitutively transcribed into translatable mRNA but the protein was rapidly degraded in the absence of its complex partner, CK8. Secondly, under certain conditions external environmental factors may play an important role in modulating epithelial differentiation. Cultured rabbit skin, corneal and oesophageal epithelial cells have been shown to express more keratin proteins than were originally present in intact tissues or observed in cysts formed by cultured cells in athymic mice (Doran et al, 1980) . Thirdly, a new subclone arises from the descendants of the original transformed cell and, with progressive growth in vitro, the cell population becomes enriched with those variants that produce CK20 (Tannock, 1987) . Some cholangiocarcinomas of the liver have demonstrated a positive reactivity for CK20, whereas all nonneoplastic bile ducts and ductules were negative, suggesting a correlation between the CK20 expression and neoplastic transformation of the bile duct (Maeda et al, 1996) .
In summary, six newly established human ovarian carcinoma cell lines that were derived from solid tumours have been investigated in terms of their immunohistochemical properties, including IF expression. All six cell lines were positive for CKs 7, 8, 18 and 19. In the past, the expression of CK20 has been considered to be entirely confined to the mucosa of the small and large intestine. Although CK20 was not expressed in the original ovarian tumours, two of the six cell lines (one clear-cell adenocarcinoma and one serous papillary adenocarcinoma) expressed CK20, as did the heterotransplanted tumours produced by those CK20-positive cell lines. These cell lines will provide a relevant experimental system for assessing the regulatory control mechanisms of IF expression, including a family of CKs.
